SP Scientific Invests in Training & Demonstration Laboratory Facility
SP Scientific has announced further investment into its state-of-the-art training and demonstration laboratory facility.**
The demonstration laboratory will now be able to offer customers and potential clients the opportunity to book an appointment to test/demo SP Scientific’s latest products including the AdVantage Pro, Benchtop Pro and LyoStar 3 Freeze Dryer with SMART, ControLyo and TDLAS. If required, specialty items can be brought in upon customer request.
The 1200 sq ft facility will also continue to accommodate SP Scientific's popular 4-day Lyophilization Laboratory training courses (www.spscientific.com/HandsOnTraining/). The next course, due to run from 30 September– 3 October 2014, will cover freeze drying and cycle optimization techniques and focus on the freeze drying process from formulation and thermal analysis to cycle development and optimization, packaging, and troubleshooting. The course will include hands-on use of freeze dryers, as well as other equipment and technology used in lyophilization cycle development, such as differential scanning calorimetry, freeze dry microscopy and moisture analysis.
In addition to providing an extensive demonstration and training capability, the SP Scientific course allows attendees the chance at in-depth discussions with application specialists to investigate the feasibility and optimize freeze drying cycles for their products. To date, over 150 attendees from pharmaceutical and biotechnical companies throughout the world have attended this one-of-kind course.
SP Scientific is a leading manufacturer of laboratory to production scale freeze dryers/lyophilizers, centrifugal evaporators and concentrators, thermal control system and glassware washers. The company sells its products under well-known brands including VirTis, Hull, FTS Systems, Genevac, and National-Hotpack. SP Scientific has ISO 9001:2008 registered production facilities in the USA and Europe.
To book an appointment to try out equipment, please contact SP Scientific on +1 845 255 5000 or email [email protected]
** Facility located at facility in at its Warminster, PA site.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance